What's Next For Pharma R&D In Asia? ----Decode Big Pharma's R&D Strategies ...

What’s Next For Pharma R&D In Asia?
----Decode Big Pharma’s R&D Strategies in Asia Pharma R&D Leaders 2011

Asia Pharma R&D Leaders will be coming back to Shanghai for the 2nd year with a more Prominent Speaker Line-up and topics! Based on the success of the 2010 version, this event will attract over 250 senior-level decision makers working R&D, Translational Sciences, Clinical Development, Licensing and external research and business development from big Pharma and biotech companies to tackle the crucial issues facing the industry. It’s definitely a Must-Attend event for you to optimize your pharma R&D cost efficiency and gain competitiveness in Asia Pacific.

The 2 nd Asia Pharma R&D Leaders will examine issues such as Pharma partnering models, licensing opportunities, risk management approaches, outsourcing strategies, IP management, and latest pharma research advancement on sequencing, biomarkers, preclinical imaging, data management etc.

Confirmed speakers include:

Steve Yang, Vice President, Head of Asia R&D, Pfizer
Davinder Gill, PhD VP/Head Global Biotherapeutics Technologies Pfizer
Gerd Maass, Global Head of Biomarker and Pathway Analysis, Roche Pharma Research and Early Development
Ruiping Dong, MD &PhD, SVP, Head of Emerging Market R&D
Xiaolin Zhang, Ph.D. vice president & head of AstraZeneca Innovation Center China (ICC)
Xin Ma, Head of Global Drug Discovery - Innovation Center China Bayer Schering Pharma
Binhui Ni, Ph.D., Head of Scouting and Partnering, China Sanofi-Aventis
Canwen Jiang , MD, PhD VP & Head of R&D Asia Genzyme Corporation 
Baoping Wang, Vice President & Head of Novo Nordisk ( China ) R&D Center
Ming Qiang Zhang , VP / CTO Roche R&D China
Peter Hongaard Andersen , Executive Vice President for Research of  H Lundbeck A/S
Jingsong Wang, M.D. Director, Discovery Medicine & Clinical Pharmacology, Bristol-Myers Squibb
Lee E Babiss , Executive Vice President of Global Laboratory, PPD
Jonathon D. Sedgwick , Managing Director & Chief Scientific Officer, Lilly Singapore Centre for Drug Discovery
Paul B Bolno, MD, MBA Vice President, Worldwide Business Development Head of Asia GlaxoSmithKline
Jingkang Shen , Deputy Director Shanghai Institute of Materia Medica
Biao Jiang , Vice President Shanghai Advanced Research Institute, Chinese Academy of Sciences
Yizhun Zhu, Ph.D.Dean of School of Pharmacy and Director, Institute of Drug R&D Fudan University
Swami Subramaniam MD, PhD Director – Licensing and External Research ( India and SE Asia ), Merck and Co., Inc
Frank Grams , Executive Director Roche Pharma Partnering, Asia
Samantha Du, President Hutchison Medipharm
Jennifer Hu , Director of Licensing & External Research ( Mainland China , Hong Kong & Taiwan ) Merck & Co., Inc

Current Sponsors for this event are:

BGI (Beijing Genomics Institute), AMRI (Albany Molecular Research, Inc.) , McKinsey&Company , Sundia , Ricerca Biosciences , PPC (Protech Pharmaservices Corporation), Finnegan, Henderson, Farabow, Garrett & Dunner, LLP , M+W Group , Crown Bioscience , etc.

For more information on registration and sponsoring/exhibiting, please contact:

Daniel Chen
Global Leaders Institute
Phone: +86-21-3251-6046
Email: daniel.chen@globaleaders.com

SOURCE: Global Leaders Institute

RELATED LINKS

www.globaleaders.com